Pharma Stocks
-
South Korean shares hit fresh record as chip, pharma stocks rally
End-of-day quote Monde 02:50:00 2025-09-23 am EDT 5-day change 1st Jan Change 3,486.19 PTS +0.51% +1.06% +45.29% Published on 09/23/2025…
Read More » -
Natco Pharma Faces Bearish Technical Trends Amid Market Evaluation Revision
Natco Pharma, a small-cap pharmaceutical company, has recently revised its stock evaluation amid challenging market conditions. Currently priced at 864.55,…
Read More » -
DongKoo Bio & Pharma Co., Ltd.’s (KOSDAQ:006620) Price Is Out Of Tune With Earnings
DongKoo Bio & Pharma Co., Ltd.’s (KOSDAQ:006620) price-to-earnings (or “P/E”) ratio of 26.2x might make it look like a strong…
Read More » -
Stocks to Watch: KFin Technologies, Brigade Enterprises, RVNL and more
1 / 10 Private equity firm General Atlantic may sell a 10–15% stake in KFin Technologies through block deals at…
Read More » -
POST-MARKET SUMMARY 22nd September 2025
Indian benchmark indices started the week on a negative note, extending their losing streak for the second consecutive day. The…
Read More » -
European Stocks Hold Steady As Pharma And Chip Firms Stand Out
What’s going on here? European stocks trading as American depositary receipts (ADRs) in the US held their ground last session,…
Read More » -
A Look at Astellas Pharma (TSE:4503) Valuation Following Japan’s Conditional Approval of IZERVAY for Geographic Atrophy
If you have been watching Astellas Pharma (TSE:4503), the latest regulatory news might have you wondering what comes next. The…
Read More » -
Extended Debt Maturity and EBITDA Covenant Might Change the Case for Investing in Ligand Pharmaceuticals (LGND)
On September 12, 2025, Ligand Pharmaceuticals announced a third amendment to its credit agreement, extending the maturity date to September…
Read More » -
Sensex Today | Stock Market Highlights: Nifty, Sensex turn weak as H-1B visa issue drags IT names
Sensex Today | Stock Market Highlights: Weakness in IT dragged the broader indices, with the Sensex slipping 466 points to…
Read More » -
Shukra Pharmaceuticals Achieves 52-Week High Amid Strong Market Performance Trends
Shukra Pharmaceuticals has achieved a new 52-week high of Rs. 31.87, showcasing significant growth in the Pharmaceuticals & Biotechnology sector.…
Read More »